GAL-9 affects AML cells through an autocrine loop with TIM-3, leading to activation of survival signaling pathways and directing the ability of AML blasts to self-renew [31] and/or affect immune cells, thus participating in the mechanisms by which AML blasts escape control of the immune system [24,69]. Here, HAVCR2 is linked to acute myeloid leukemia.